BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18509183)

  • 21. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritumoral overexpression of ZBP-89 is associated with unfavorable disease-free survival rates in patients with hepatocellular carcinoma following hepatectomy.
    Wang QS; Chen C; Zhan J; Fang XF; Chen GG; Yang SL; Chen RW; Tong F; Hu JL
    Oncol Lett; 2018 May; 15(5):7828-7836. PubMed ID: 29731904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma.
    Zhang JB; Guo K; Sun HC; Zhu XD; Zhang B; Lin ZH; Zhang BH; Liu YK; Ren ZG; Fan J
    Br J Cancer; 2013 Sep; 109(6):1648-56. PubMed ID: 24002609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.
    Ju MJ; Qiu SJ; Fan J; Xiao YS; Gao Q; Zhou J; Li YW; Tang ZY
    Am J Clin Pathol; 2009 Apr; 131(4):498-510. PubMed ID: 19289585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma.
    Dai X; Xue J; Hu J; Yang SL; Chen GG; Lai PBS; Yu C; Zeng C; Fang X; Pan X; Zhang T
    Transl Oncol; 2017 Aug; 10(4):511-517. PubMed ID: 28558264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of hepatocyte nuclear factors 4α and 1α identified by tissue microarray in resectable hepatocellular carcinoma.
    Shim JH; Kang HJ; Han S; Lee YJ; Lee SG; Yu E; Lee HC
    J Gastroenterol Hepatol; 2014 Mar; 29(3):524-32. PubMed ID: 23981200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
    Yamanaka J; Yamanaka N; Nakasho K; Tanaka T; Ando T; Yasui C; Kuroda N; Takata M; Maeda S; Matsushita K; Uematsu K; Okamoto E
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1192-8. PubMed ID: 11106101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy.
    Donadon M; Di Tommaso L; Soldani C; Franceschini B; Terrone A; Mimmo A; Vitali E; Roncalli M; Lania A; Torzilli G
    Liver Int; 2018 Feb; 38(2):303-311. PubMed ID: 28727243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection.
    Wang JX; Yi Y; Li YW; Cai XY; He HW; Ni XC; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    BMC Cancer; 2014 Apr; 14():297. PubMed ID: 24774224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
    Kim SH; Ahn S; Park CK
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
    von Felden J; Heim D; Schulze K; Krech T; Ewald F; Nashan B; Lohse AW; Wege H
    BMC Cancer; 2017 Jan; 17(1):60. PubMed ID: 28100188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
    Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.